Exploring new ways to use peptides for pain relief
Chemical biology of Peptide Regulation of Opioid Receptor Function
This study is looking at how certain tiny proteins can change how pain-relieving receptors in our bodies work, with the goal of finding new ways to help manage pain safely and effectively, especially for those who need alternatives to traditional opioids like morphine.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10789891 on NIH RePORTER |
What this research studies
This research investigates how specific peptides can influence the function of opioid receptors, which are critical in pain management. By focusing on the N-terminal domain of human opioid receptors, the project aims to discover new therapeutic agents that can alleviate pain with fewer side effects compared to traditional opioids like morphine. The approach involves detailed biochemical studies and medicinal chemistry techniques to develop and test these new compounds. Patients may benefit from safer and more effective pain management options as a result of this research.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic pain conditions who are seeking alternative pain management therapies.
Not a fit: Patients who do not experience pain or those who are not interested in alternative pain management strategies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new pain relief treatments that minimize the risk of addiction and other side effects associated with current opioid medications.
How similar studies have performed: Other research has shown promise in developing new pain management strategies targeting opioid receptors, indicating that this approach could be a valuable addition to existing therapies.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Haskell-Luevano, Carrie — University of Minnesota
- Study coordinator: Haskell-Luevano, Carrie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.